These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34912001)

  • 21. [COVID-19: Would compulsory vaccination be legally possible?].
    Frielitz FS; Wagner IV; Schewe DM; Bothe K
    Dtsch Med Wochenschr; 2021 Feb; 146(3):206-208. PubMed ID: 33440433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guidance for Implementing COVID-19 Prevention Strategies in the Context of Varying Community Transmission Levels and Vaccination Coverage.
    Christie A; Brooks JT; Hicks LA; Sauber-Schatz EK; Yoder JS; Honein MA;
    MMWR Morb Mortal Wkly Rep; 2021 Jul; 70(30):1044-1047. PubMed ID: 34324480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparing the impact of vaccination strategies on the spread of COVID-19, including a novel household-targeted vaccination strategy.
    Voigt A; Omholt S; Almaas E
    PLoS One; 2022; 17(2):e0263155. PubMed ID: 35108311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Covid-19: Use social media to maximise vaccine confidence and uptake.
    Patten D; Green A; Bown D; Russell C
    BMJ; 2021 Jan; 372():n225. PubMed ID: 33500243
    [No Abstract]   [Full Text] [Related]  

  • 25. Individual preferences for COVID-19 vaccination in China.
    Leng A; Maitland E; Wang S; Nicholas S; Liu R; Wang J
    Vaccine; 2021 Jan; 39(2):247-254. PubMed ID: 33328140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cultural competence in vaccine rollout: migrants would face difficulties accessing covid-19 vaccines.
    Waterman LZ
    BMJ; 2021 Jan; 372():n220. PubMed ID: 33500270
    [No Abstract]   [Full Text] [Related]  

  • 27. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Equitable and Feasible Distribution of SARS-CoV-2 Vaccines for All in Africa.
    Rogers AB; Barrie MB; Fallah MP; Kelly JD
    Am J Trop Med Hyg; 2021 Jun; 105(2):278-280. PubMed ID: 34181573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allergic Reactions and Anaphylaxis to LNP-Based COVID-19 Vaccines.
    Moghimi SM
    Mol Ther; 2021 Mar; 29(3):898-900. PubMed ID: 33571463
    [No Abstract]   [Full Text] [Related]  

  • 30. Assessing vaccination priorities for different ages and age-specific vaccination strategies of COVID-19 using an SEIR modelling approach.
    Yang C; Yang Y; Li Y
    PLoS One; 2021; 16(12):e0261236. PubMed ID: 34936650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
    Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lessons from the United Kingdom's COVID-19 vaccination strategy.
    Harnden A; Earnshaw A
    Med J Aust; 2021 May; 214(9):417-419. PubMed ID: 33893643
    [No Abstract]   [Full Text] [Related]  

  • 33. Vaccination strategy and challenges for consolidating successful containment of covid-19 with population immunity in China.
    An Z; Wang F; Pan A; Yin Z; Rodewald L; Feng Z
    BMJ; 2021 Dec; 375():e066125. PubMed ID: 34853010
    [No Abstract]   [Full Text] [Related]  

  • 34. COVID-19 vaccines and decreased transmission of SARS-CoV-2.
    Vitiello A; Ferrara F; Troiano V; La Porta R
    Inflammopharmacology; 2021 Oct; 29(5):1357-1360. PubMed ID: 34279767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COVID-19 in the Caribbean.
    Burki TK
    Lancet Respir Med; 2021 Apr; 9(4):e46. PubMed ID: 33581745
    [No Abstract]   [Full Text] [Related]  

  • 36. Are COVID vaccination programmes working? Scientists seek first clues.
    Mallapaty S
    Nature; 2021 Jan; 589(7843):504-505. PubMed ID: 33483685
    [No Abstract]   [Full Text] [Related]  

  • 37. Increasing COVID-19 vaccine uptake in Black Americans.
    Burki T
    Lancet Infect Dis; 2021 Nov; 21(11):1500-1501. PubMed ID: 34717810
    [No Abstract]   [Full Text] [Related]  

  • 38. Multiple Variants of SARS-CoV-2 in a University Outbreak After Spring Break - Chicago, Illinois, March-May 2021.
    Doyle K; Teran RA; Reefhuis J; Kerins JL; Qiu X; Green SJ; Choi H; Madni SA; Kamal N; Landon E; Albert RC; Pacilli M; Furtado LE; Hayden MK; Kunstman KJ; Bethel C; Megger L; Fricchione MJ; Ghinai I
    MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(35):1195-1200. PubMed ID: 34473687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of an outbreak of symptomatic SARS-CoV-2 VOC 202012/01-lineage B.1.1.7 infection in healthcare workers, Italy.
    Loconsole D; Sallustio A; Accogli M; Leaci A; Sanguedolce A; Parisi A; Chironna M
    Clin Microbiol Infect; 2021 Aug; 27(8):1174.e1-1174.e4. PubMed ID: 33984489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Looking beyond COVID-19 as a pandemic.
    Lau YL
    Hong Kong Med J; 2021 Apr; 27(2):88-89. PubMed ID: 33843608
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.